Jamaal Russ v. Nike: Plant Biology Patent Case Transferred in 26 Days
Jamaal Russ filed an infringement action against Nike in the Southern District of New York asserting US6639128B1, a patent covering methods for altering organ mass, controlling fertility, and enhancing asexual reproduction in plants. The case was transferred within 26 days, before any substantive merits ruling was issued.
Plant biology patent claim against Nike shifted venue after 26 days
On April 18, 2025, Jamaal Russ filed a patent infringement action against Nike in the Southern District of New York, asserting US6639128B1 — a patent directed at methods for altering organ mass, controlling fertility, and enhancing asexual reproduction in plants. The case was assigned to Chief Judge Laura Taylor Swain. The filing is notable for the apparent technological distance between the asserted patent’s plant biology subject matter and Nike’s core commercial activities in footwear and apparel.
The case closed on May 14, 2025, just 26 days after filing, on the basis of a case transfer. The transfer followed a Report and Recommendation issued by Magistrate Judge Talesha L. Saint-Marc on April 16, 2025 — notably pre-dating the complaint’s April 18 filing date as recorded — and was approved by Chief Judge Landya B. McCafferty on May 19, 2025. The judgment entry effectuates the transfer rather than resolving any substantive infringement question.
The 26-day resolution timeline suggests that procedural deficiencies or venue issues were identified very early, consistent with a sua sponte or early-stage transfer order. The public record does not disclose the receiving venue, the precise grounds for transfer, or whether the plaintiff was represented by counsel at any point. The mismatch between the plant biology patent and the named defendant may have been a material factor in the transfer determination.
Filing to Case Transferred in 26 days
Case resolved by transfer order — well under the median district court lifecycle
Case transferred: what a venue change means for both parties
What a case transfer means procedurally
A transfer order moves the case from the filing court to a different federal district, typically under 28 U.S.C. § 1404(a) for convenience or § 1406(a) for improper venue. No merits ruling is issued by the transferring court. The Southern District of New York made no finding on infringement, validity, or damages — the slate is reset in the receiving court, which starts fresh with jurisdiction over the matter.
No merits decidedRuss retains the right to pursue claims in the new venue
A transfer without prejudice to the merits means Jamaal Russ’s infringement claims survive and travel with the case to the receiving court. However, the plaintiff will face the same substantive challenges there — including demonstrating how a plant biology patent applies to Nike’s products. The receiving court may also scrutinize standing, claim construction, and complaint adequacy at the outset.
Claims survive transferNike faces no S.D.N.Y. ruling — litigation continues elsewhere
Nike obtained no dismissal or favorable merits ruling in New York. The transfer means Nike must respond to the complaint in whichever federal district receives the case. Nike will likely move to dismiss on substantive grounds — including lack of infringement nexus between a plant biology patent and its footwear or apparel business — once the case is docketed in the new venue.
Litigation ongoing in new venueTransfer signals early procedural scrutiny of venue and claim plausibility
The rapid transfer — within 26 days and before any substantive briefing — is consistent with courts exercising early gatekeeping on cases where venue or claim plausibility is facially questionable. For IP professionals, this case illustrates how courts can redirect litigation quickly when the filing court appears to lack a sufficient nexus to the defendant’s conduct or the asserted technology’s commercial application.
Early venue gatekeepingFull party and counsel information
| Role | Name | Type | Detail |
|---|---|---|---|
| Plaintiff | Jamaal Russ | Individual | Pro se patent holder asserting US6639128B1 — plant biology methods patentSearch in Eureka ↗ |
| Defendant | Nike | Individual | Nike — global footwear and apparel company named as patent defendantSearch in Eureka ↗ |
| Plaintiff counsel | Jamaal Russ | Attorney | Counsel for Jamaal RussSearch in Eureka ↗ |
| Presiding judge | Judge Laura Taylor Swain | Judge | New York Southern District CourtSearch in Eureka ↗ |
Official order — verbatim text
The judgment entry references approval of a Magistrate Judge’s Report and Recommendation, indicating the transfer followed a structured judicial review process rather than a unilateral sua sponte order. Notably, the Report and Recommendation predates the recorded filing date, which may reflect a related or earlier-filed matter. The judgment confers no finding on infringement, validity, or damages — it functions solely as a procedural disposition directing the matter to a more appropriate forum.
US6639128B1 — Plant organ mass, fertility control and asexual reproduction methods
US6639128B1 (application no. US09/479855) covers methods directed at altering organ mass, controlling fertility, and enhancing asexual reproduction in plants. This places the patent squarely in the plant molecular biology and agricultural biotechnology domain. Patents of this type typically protect genetic or biochemical interventions that modulate plant development pathways — commercially relevant to seed companies, agrochemical developers, and horticultural biotech firms.
The strategic significance of US6639128B1 depends heavily on its claim scope relative to current plant biotech practices. If broadly drafted, methods covering organ mass alteration could touch applications in crop yield optimisation or biomass engineering. Its assertion against Nike — a footwear and apparel company — is commercially atypical and suggests either a novel infringement theory tied to plant-derived materials, or a claim-defendant mismatch that courts may find implausible on its face.
Should you run an FTO against US6639128B1?
R&D and product teams in agricultural biotechnology, plant science, horticulture, and any sector working with plant-derived biomaterials should assess whether their processes intersect with the claimed methods of US6639128B1. Given the patent’s coverage of organ mass alteration and fertility control in plants, developers of GM crops, propagation systems, or bio-based feedstock processes face the highest exposure risk. The case’s transfer does not reduce the patent’s enforceability.
PatSnap Eureka’s FTO Search Agent can map the claims of US6639128B1 against your product pipeline, identify prior art that may limit enforceability, and flag any continuation or divisional applications that extend related coverage. With the case now pending in a new venue, monitoring the transferred docket for claim construction orders is equally important for freedom-to-operate planning.
Run a freedom-to-operate analysis on US6639128B1 to assess your product’s exposure
Run FTO in Eureka →Similar plant biology and agricultural patent cases in U.S. district courts
Explore patent infringement cases involving plant biology, agricultural biotech, and molecular plant science methods litigated in U.S. district courts, including S.D.N.Y.
What this case signals for the plant biology and IP enforcement landscape
A rapid transfer before any merits ruling highlights the procedural risks of asserting technically narrow patents against defendants in apparently unrelated industries.
Early transfer orders are a red flag for claim-defendant mismatch
When a case transfers within 26 days of filing, it typically signals that venue, jurisdiction, or complaint adequacy were immediately problematic. IP teams monitoring enforcement trends should treat rapid transfers as indicators of structural weakness in the plaintiff’s case theory — particularly where patent subject matter appears disconnected from the defendant’s product portfolio.
US6639128B1 remains live and assertable in the receiving court
The transfer does not extinguish the patent or its claims. Companies in the plant sciences, agricultural biotechnology, or horticulture sectors whose products touch organ mass modification, plant fertility control, or asexual reproduction methods should monitor the docket in the receiving venue for any substantive claim construction or infringement rulings that follow.
Russ v Nike — key questions answered
Jamaal Russ filed a patent infringement action against Nike in the Southern District of New York on April 18, 2025, asserting US6639128B1. The case was transferred to a different federal venue within 26 days, with no merits ruling on infringement or validity issued by the S.D.N.Y. court.
US6639128B1 (app. no. US09/479855) covers methods for altering organ mass, controlling fertility, and enhancing asexual reproduction in plants — a plant molecular biology patent. The basis for asserting it against Nike, a footwear and apparel company, is not explained in the public docket and represents an atypical claim-defendant pairing that likely contributed to early judicial scrutiny.
The case transferred within 26 days, consistent with early identification of venue or procedural defects. A Magistrate Judge’s Report and Recommendation preceded the formal filing date on record, suggesting possible related proceedings or early judicial review. The public record does not disclose the specific transfer grounds or the receiving court.
No. A case transfer is a procedural disposition only. US6639128B1 remains issued and enforceable. The infringement claims travel with the case to the receiving court, where substantive proceedings — including claim construction and motions to dismiss — may follow. Companies in plant biotech and agricultural methods should continue to monitor the patent’s status.
The transfer was effected through a Magistrate Judge’s Report and Recommendation adopted by Chief Judge McCafferty, indicating the court followed a deliberate referral and review process rather than an ad hoc order. This structure is consistent with 28 U.S.C. § 636(b) referrals and suggests the procedural issue warranting transfer was substantive enough to merit formal judicial analysis before disposition.
PatSnap Eureka searches patents and litigation data to answer instantly.